ScinoPharm is the largest pharmaceutical company in Taiwan and boosts a comprehensive R&D capability. Our technical capabilities include the organic synthesis of small molecules and peptide APIs. Our global customers include the world's top patented pharmaceutical companies and top ten generic drugs manufacturers.
Since becoming profitable in 2006, ScinoPharm has grown significantly in both revenues and profits, becoming one of the most profitable domestic companies. All these achievements highlight ScinoPharm's strong operating strength and growth potential.